A statistical evaluation is presented, which reveals a significantly improved survival of children with nephrosis under modern management. The status of the survivors in a small sample seems much better in the current series. The evidence that such improvement is due to the more intensive use of adrenalactive steroid therapy is circumstantial but highly credible. A program for steroid administration, which has seemed satisfactory, is presented. The risks inherent in such hormone treatment appear to be more than counterbalanced by the reduction in early mortality.